Recall immune memory: A new tool for generating late onset autoimmune myasthenia gravis

Mechanisms of Ageing and Development

Volumn 124, Issue 8-9, 2003, Pages 931-940

  Stacy, Sue ^a   Infante, Anthony J ^a   Wall, Katherine A ^b   Krolick, Keith ^a   Kraig, Ellen ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Autoimmunity; B lymphocytes; Immunological memory

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALE; MEMORY CELL; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RECALL;

ANIMALIA; TORPEDO; TORPEDO CALIFORNICA;

EID: 0141629738     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(03)00165-9     Document Type: Article

References (57)

1. Arreaza E.E., Gibbons J.J. Jr., Siskind G.W., Weksler M.E. Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans. Clin. Exp. Immunol. 92:1993;169-173.
2. Bender B.S., Tallman E., Johnson M.P., Small P.A.J. Enhancement of anti-influenza cytotoxic T-lymphocyte activity in senescent mice by vaccination early in life. Mech. Ageing Dev. 55:1990;1-7.
3. Berman P.W., Patrick J. Experimental myasthenia gravis. A murine system. J. Exp. Med. 151:1980;204-223.
4. Borch K., Liedberg G. Prevalence and incidence of pernicious anemia. An evaluation for gastric screening. Scand. J. Gastroenterol. 19:1984;154-160.
5. Bovbjerg D.H., Kim Y.T., Schwab R., Schmitt K., DeBlasio T., Weksler M.E. 'Cross-wiring' of the immune response in old mice: increased autoantibody response despite reduced antibody response to nominal antigen. Cell. Immunol. 135:1991;519-525.
6. Brown R.M., Krolick K.A. Clonotypic analysis of the antibody response to the acetylcholine receptor in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 19:1988;205-222.
7. Christensen P.B., Jensen T.S., Tsiropoulos I., Sorensen T., Kjaer M., Hojer-Pedersen E., Rasmussen M.J., Lehfeldt E., de Fine O.B. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology. 43:1993;1779-1783.
8. Compston D.A., Vincent A., Newsom-Davis J., Batchelor J.R. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain. 103:1980;579-601.
9. Davenport F.M., Hennessy A.V. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J. Exp. Med. 106:1957;835-850.
10. Drachman D.B., Adams R.N., Josifek L.F., Self S.G. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med. 307:1982;769-775.
11. Engel A. Acquired autoimmune myasthenia gravis. Engel A.G., Franzini-Armstrong C. Myology. 1994;1769-1797 McGraw-Hill, New York.
12. Fagiolo U., Amadori A., Biselli R., Paganelli R., Nisini R., Cozzi E., Zamarchi R., D'Amelio R. Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin. Vaccine. 11:1993;1336-1340.
13. Faulkner J.A., Brooks S.V., Zerba E. Muscle atrophy and weakness with aging: contraction-induced injury as an underlying mechanism. J. Gerontol. A. 50:1994;124-129.
14. Gahring L.C., Weigle W.O. The effect of aging on the induction of humoral and cellular immunity and tolerance in two long-lived mouse strains. Cell. Immunol. 128:1990;142-151.
15. Gardner E.M., Murasko D.M. Age-related changes in type 1 and type 2 cytokine production in humans. Biogerontol. 3:2002;271-290.
16. Graus Y.M., Verschuuren J.J., Bos N.A., van Breda Vriesman P.J., De Baets M.H. VH gene family utilization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 43:1993;113-124.
17. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Adv. Immunol. 80:2002;243-284.
18. Gu Y., Camacho P., Gardner P., Hall Z.W. Identification of two amino acid residues in the epsilon subunit that promote mammalian muscle acetylcholine receptor assembly in COS cells. Neuron. 6:1991;879-887.
19. Harrod T., Martin M., Russell M.W. Long-term persistence and recall of immune responses in aged mice after mucosal immunization. Oral Microbiol. Immunol. 16:2001;170-177.
20. Hoedemaekers A.C., Verschuuren J.J., Spaans F., Graus Y.F., Riemersma S., van Breda Vriesman P.J., De Baets M.H. Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects. Muscle Nerve. 20:1997;1091-1101.
21. Klinman N.R., Kline G.H. The B-cell biology of aging. Immunol. Rev. 160:1997;103-114.
22. Kurashima C., Utsuyama M. Age-related changes of cytokine production by murine helper T cell subpopulations. Pathobiology. 65:1997;155-162.
23. Larsson L. Motor units: remodeling in aged animals. J. Gerontol. A. 50:1994;91-95.
24. Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis. Adv. Immunol. 42:1988;233-284.
25. Machens A., Loliger C., Pichlmeier U., Emskotter Th., Busch C., Izbicki J.R. Correlation of thymic pathology with HLA in myasthenia gravis. Clin. Immunol. 91:1999;296-301.
26. Maletto B., Gruppi A., Pistoresi-Palencia M.C. Aging: the cellular immune response against autologous and foreign antigens is affected before the humoral response. Immunol. Lett. 40:1994;243-250.
27. Manoussakis M.N., Tzioufas A.G., Silis M.P., Pange P.J., Goudevenos J., Moutsopoulos H.M. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin. Exp. Immunol. 69:1987;557-565.
28. McElhaney J.E., Meneilly G.S., Lechelt K.E., Beattie B.L., Bleackley R.C. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine. 11:1993;1055-1060.
29. Meinl E., Klinkert W.E., Wekerle H. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Amer. J. Pathol. 139:1991;995-1008.
30. Miller C., Kelsoe G. Ig VH hypermutation is absent in the germinal centers of aged mice. J. Immunol. 155:1995;3377-3384.
31. Miller R. Immune system. Masoro E.J. Handbook of Physiology: Aging. 1995;555-589 Oxford Press, NY.
32. Mishra N., Kammer G.M. Clinical expression of autoimmune diseases in older adults. Clin. Geriatr. Med. 14:1998;515-542.
33. Mohan S., Barohn R.J., Jackson C.E., Krolick K.A. Evaluation of myosin-reactive antibodies from a panel of myasthenia gravis patients. Clin. Immunol. Immunopathol. 70:1994;266-273.
34. Nicoletti C., Borghesi-Nicoletti C., Yang X.H., Schulze D.H., Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity. J. Immunol. 147:1991;2750-2755.
35. Nicoletti C., Yang X., Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J. Immunol. 150:1993;543-549.
36. Olsberg C.A., Maxwell L.C., Mikiten T.M., Krolick K.A. Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor. J. Neuroimmunol. 14:1987;253-266.
37. Phillips L.H., Torner J.C., Anderson M.S., Cox G.M. The epidemiology of myasthenia gravis in central and western Virginia. Neurology. 42:1992;1888-1893.
38. Poulas K., Tsibri E., Kokla A., Papanastasiou D., Tsouloufis T., Marinou M., Tsantili P., Papapetropoulos T., Tzartos S.J. Epidemiology of seropositive myasthenia gravis in Greece. J. Neurol. Neurosurg. Psychiatry. 71:2001;352-356.
39. Powers D.C., Belshe R.B. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and 'original antigenic sin'. J. Infect. Dis. 169:1994;1125-1129.
40. Riley S.C., Froscher B.G., Linton P.J., Zharhary D., Marcu K., Klinman N.R. Altered VH gene segment utilization in the response to phosphorylcholine by aged mice. J. Immunol. 143:1989;3798-3805.
41. Rink L., Cakman I., Kirchner H. Altered cytokine production in the elderly. Mech. Ageing Dev. 102:1998;199-209.
42. Sambhara S., Kurichh A., Miranda R., James O., Underdown B., Klein M., Tartaglia J., Burt D. Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses. Cell. Immunol. 210:2001;1-4.
43. Sanchez M., Lindroth K., Sverremark E., Gonzalez F.A., Fernandez C. The response in old mice: positive and negative immune memory after priming in early age. Int. Immunol. 13:2001;1213-1221.
44. Saoudi A., Bernard I., Hoedemaekers A., Cautain B., Martinez K., Druet P., De Baets M., Guery J.C. Polarization toward the T-helper (Th) 1 type immune response is not required for rat experimental autoimmune myasthenia gravis. Transplant Proc. 31:1999;1604-1605.
45. Schulze D.H., Goidl E.A. Age-associated changes in antibody-forming cells (B cells). Proc. Soc. Exp. Biol. Med. 196:1991;253-259.
46. Schwab R., Walters C.A., Weksler M.E. Host defense mechanisms and aging. Semin. Oncol. 16:1989;20-27.
47. Shenoy M., Kaul R., Goluszko E., David C., Christadoss P. Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis. J. Immunol. 153:1994;5330-5335.
48. Sitaraman S., Metzger D.W., Belloto R.J. Jr., Infante A.J., Wall K.A. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice. J. Neuroimmunol. 107:2000;73-82.
49. Stacy S., Krolick K.A., Infante A.J., Kraig E. Immunological memory and late onset autoimmunity. Mech. Ageing Dev. 123:2002;975-985.
50. Thompson P.A., Krolick K.A. Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: subsetting of serum antibodies by preparative isoelectric focusing. Clin. Immunol. Immunopathol. 62:1992;199-209.
51. Tournier-Lasserve E., Bach J.F. The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models. J. Neuroimmunol. 47:1993;103-114.
52. Wang L.C., Kernell D. Fibre type regionalisation in lower hindlimb muscles of rabbit, rat and mouse: a comparative study. J. Anat. 199:2001;631-643.
53. Weksler M.C., Innes J.D., Goldstein G. Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice. J. Exp. Med. 148:1978;996-1006.
54. Weksler M.E., Szabo P. The effect of age on the B-cell repertoire. J. Clin. Immunol. 20:2000;240-249.
55. Weksler M.E., Goodhardt M., Szabo P. The effect of age on B cell development and humoral immunity. Springer Semin. Immunopathol. 24:2002;35-52.
56. Yang X., Stedra J., Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J. Exp. Med. 183:1996;959-970.
57. Zheng B., Han S., Takahashi Y., Kelsoe G. Immunosenescence and germinal center reaction. Immunol. Rev. 160:1997;63-77.